CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial Successful bailout stenting strategy against lethal coronary dissection involving left main bifurcation Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial

Guideline2019 Jul 1;94(1):29-37.

JOURNAL:Catheter Cardiovasc Interv. Article Link

SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019

DA Baran, CL Grines, S Bailey et al. Keywords: AMICS; SCAI

Full Text PDF